Abstract
Superselective intraophthalmic artery chemotherapy (SSIOAC) has come to the forefront in the treatment of retinoblastoma. We have presented the histopathologic and radiologic findings of a retinoblastoma patient who subsequently developed enophthalmos, choroidal ischemia, iris atrophy, and scleritis as delayed toxicities of SSIOAC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have